1. Ke, Hanni, Tang, Shuyan, Guo, Ting, Jin, Li, Chen, Zi-Jiang. 2023. Landscape of pathogenic mutations in premature ovarian insufficiency. In Nature medicine, 29, 483-492. doi:10.1038/s41591-022-02194-3. https://pubmed.ncbi.nlm.nih.gov/36732629/
2. Jia, Longlue, Zhang, Danyan, Huang, Hannian, Zhou, Shengli, Guo, Jiangfeng. 2018. Triazophos-induced toxicity in zebrafish: miRNA-217 inhibits nup43. In Toxicology research, 7, 913-922. doi:10.1039/c8tx00065d. https://pubmed.ncbi.nlm.nih.gov/30310668/
3. Tian, Chao, Zhou, Shijie, Yi, Cheng. 2018. High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer. In Future oncology (London, England), 14, 1431-1442. doi:10.2217/fon-2017-0690. https://pubmed.ncbi.nlm.nih.gov/29402145/
4. Haskell, Gloria T, Jensen, Brian C, Samsa, Leigh Ann, Evans, James P, Berg, Jonathan S. . Whole Exome Sequencing Identifies Truncating Variants in Nuclear Envelope Genes in Patients With Cardiovascular Disease. In Circulation. Cardiovascular genetics, 10, . doi:10.1161/CIRCGENETICS.116.001443. https://pubmed.ncbi.nlm.nih.gov/28611029/
5. Liu, Y-Y, Jiao, W-Y, Li, T, Bao, Y-Y. . MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia. In European review for medical and pharmacological sciences, 23, 8468-8475. doi:10.26355/eurrev_201910_19159. https://pubmed.ncbi.nlm.nih.gov/31646577/
6. Ren, Xueting, Cui, Hanxiao, Wu, Jianhua, Kang, Huafeng, Lin, Shuai. 2022. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. In Cancer medicine, 11, 3886-3901. doi:10.1002/cam4.4755. https://pubmed.ncbi.nlm.nih.gov/35441810/
7. Kong, Fan-Sheng, Lu, Zijing, Zhou, Yuan, Ma, Yaping, Chen, Jian-Huan. 2023. Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS. In Frontiers in endocrinology, 14, 1170957. doi:10.3389/fendo.2023.1170957. https://pubmed.ncbi.nlm.nih.gov/37547318/